The Delivery Problem: Why Peptides Are So Hard to Formulate

Peptides are often discussed as one of the most exciting areas in modern molecular research, but behind the enthusiasm is a stubborn technical reality: peptides can be difficult to deliver.

A peptide may look promising in a laboratory setting. It may have a carefully designed sequence, a defined structure, and a compelling research rationale. But none of that automatically solves the practical question of formulation.

How does the molecule remain stable? How is it protected from degradation? How does it cross biological barriers? How is it absorbed, distributed, measured, stored, and manufactured consistently?

This is the delivery problem.

For peptide researchers, formulation scientists, analytical teams, and manufacturers, delivery is not a small detail to be addressed later. It can shape the entire development path.

Why Peptides Are Different Peptides sit between small molecules and larger biologics.

Why Peptides Are Different

Peptides sit between small molecules and larger biologics. They are generally larger and more chemically complex than many small molecules, but smaller than full proteins or antibodies. This middle position is part of what makes them scientifically interesting, but it also creates formulation challenges.

Many peptides are vulnerable to enzymatic degradation, chemical instability, aggregation, oxidation, hydrolysis, adsorption, and changes caused by pH, temperature, agitation, ionic strength, and excipients. A recent review in Pharmaceutics notes that peptide and protein therapeutics can lose activity through mechanisms such as denaturation, adsorption, aggregation, oxidation, and hydrolysis, with stability affected by manufacturing and storage conditions.

In other words, a peptide is not just a molecule that needs to reach a target. It is a molecule that must survive the journey.

That journey can be especially difficult when researchers are studying non-injectable delivery routes, including oral, buccal, sublingual, nasal, transdermal, pulmonary, or other delivery systems.

Why Oral Peptide Delivery Is So Difficult

Oral delivery is one of the most widely discussed frontiers in peptide formulation research because it is also one of the hardest.

The gastrointestinal tract is designed to break down biological material. That is useful for digestion, but it creates major barriers for peptides. Oral peptide delivery faces challenges such as enzymatic degradation, poor stability, limited permeability, mucus barriers, epithelial transport limits, and low oral bioavailability. Recent reviews identify these as central obstacles in oral peptide delivery research.

A peptide taken through the GI tract may encounter acidic conditions in the stomach, digestive enzymes, bile salts, mucus, intestinal membranes, and tight junctions between epithelial cells. Each of these can reduce the amount of intact peptide available for absorption.

That is why oral peptide delivery is not simply a question of putting a peptide into a capsule.

It is a question of engineering a protected, controlled, timed, and transport-aware system.

The Four Main Barriers

The delivery problem can be understood through four major barriers: stability, protection, permeability, and reproducibility.

1. Stability

Peptides may degrade during storage, manufacturing, or biological exposure. They may be sensitive to pH, heat, light, moisture, agitation, or interactions with formulation components. Some peptides oxidize. Others aggregate. Some adsorb to container surfaces or degrade during processing.

This makes formulation more than a packaging issue. It becomes a chemical and physical stability problem.

Researchers must ask:

What conditions preserve the peptide?What excipients improve stability?What degradation products appear over time?How does temperature affect the molecule?Can the formulation survive manufacturing, shipping, and storage?Can analytical methods detect meaningful changes?

A stable formulation is not assumed. It has to be demonstrated.

2. Protection From Enzymes

Peptides are made of amino acids linked by peptide bonds. Proteases and peptidases are designed to cut those bonds.

This is one of the central reasons peptide delivery is hard. In the GI tract, enzymes can fragment peptides before they reach absorption sites. Some formulation strategies therefore focus on protecting peptides from enzymatic degradation.

One 2025 study on self-emulsifying drug delivery systems, or SEDDS, explored systems designed to protect a model peptide from intestinal brush border membrane-bound enzymes, using hydrophobic ion pairing to incorporate the peptide into the formulation.

This kind of work illustrates the practical nature of the delivery problem. Researchers are not only asking whether a peptide is active in a controlled assay. They are asking whether a formulation can help it remain intact long enough to be meaningfully studied in a delivery context.

3. Permeability

Even if a peptide survives, it still has to cross a barrier.

Many peptides are relatively large, hydrophilic, and polar compared with typical orally absorbed small molecules. These properties can limit passive diffusion across epithelial membranes. Mucus layers and tight junctions add further complexity.

The Pharmaceutics review describes strategies such as structural modification, absorption enhancers, prodrug approaches, targeted delivery systems, mucus-penetrating systems, mucoadhesive systems, hydrophobic ion pairing, enzyme inhibitors, and functional excipients as areas of research for addressing oral peptide and protein delivery barriers.

This is why peptide delivery research often sits at the intersection of chemistry, biology, materials science, and formulation engineering.

4. Reproducibility

A delivery system must be reproducible.

It is not enough for a formulation to work once in a small experiment. Researchers need consistent particle size, loading efficiency, release behavior, stability, purity, and performance across batches. The more complex the system, the harder this becomes.

This is especially important for enabling technologies such as nanoparticles, emulsions, self-emulsifying systems, hydrogels, implants, patches, or 3D-printed dosage forms. Each added layer of engineering may introduce new variables.

That is why analytical methods, quality control, process development, and manufacturing science are part of the delivery conversation.

Hydrophobic Ion Pairing: Making Peptides More Formulation-Friendly

One important strategy in peptide formulation research is hydrophobic ion pairing, often abbreviated HIP.

Many peptides are hydrophilic, which can make them difficult to incorporate into lipid-based systems. Hydrophobic ion pairing uses counterions to create a more lipophilic complex, which may allow the peptide to be loaded into systems such as self-emulsifying or self-nanoemulsifying drug delivery systems.

Recent literature continues to explore HIP as part of oral peptide delivery research. A 2026 open-access study developed an oral self-nanoemulsifying drug delivery system using insulin as a model peptide and employed a hydrophobic ion pairing strategy to improve incorporation into the system.

A broader review of multifunctional self-emulsifying systems notes that hydrophobic ion pairing, hydrogen-bond pairing, and prodrug approaches are used to increase the lipophilic character of hydrophilic peptide and protein molecules enough for incorporation into SEDDS-type systems.

The key point is not that HIP is a universal solution. It is that formulation scientists are finding chemical ways to make peptides behave differently inside delivery systems.

Self-Emulsifying and Self-Nanoemulsifying Systems

Self-emulsifying drug delivery systems, or SEDDS, and self-nanoemulsifying drug delivery systems, or SNEDDS, are another major area of research.

These systems are designed to form fine emulsions or nanoemulsions when exposed to aqueous environments, such as fluids in the gastrointestinal tract. For peptides, the goal is often to improve protection, dispersion, absorption potential, or formulation compatibility.

A 2025 review of novel enabling strategies for oral peptide delivery specifically lists nanomedicines, SNEDDS, ion pairing, 3D printing, and peptide-related examples among the technologies under discussion.

SEDDS and SNEDDS remain technically complex. Researchers must manage excipient selection, peptide loading, droplet size, release behavior, stability, enzyme exposure, and compatibility with the peptide’s properties.

They represent the kind of delivery platform that sounds simple in concept but requires deep formulation work in practice.

3D Printing and Personalized Dosage Architecture

Another emerging topic in peptide formulation research is 3D printing.

In pharmaceutical research, 3D printing can be used to explore dosage-form geometry, release profiles, layering, compartmentalization, and manufacturing flexibility. In peptide delivery, the interest is not just in printing a tablet. It is in designing physical architecture around the molecule.

Could a dosage form protect a peptide in one environment and release it in another?Could geometry influence release timing?Could layered systems separate incompatible components?Could small-batch or specialized manufacturing models support research programs?

The 2025 review on novel enabling strategies identifies 3D printing among the current approaches being evaluated for oral peptide delivery systems.

This is a good example of how peptide delivery is no longer only about chemistry. It is also about device-like thinking, materials behavior, and dosage-form engineering.

The Oral Cavity as an Alternative Route

Not all non-injectable peptide delivery research focuses on the stomach and intestines.

The oral cavity, including buccal and sublingual routes, is also under investigation. These routes may offer access to vascularized mucosal tissue and may bypass some aspects of gastrointestinal degradation and first-pass metabolism.

A 2025 review in Biomedicines describes the oral cavity as a promising alternative for peptide delivery because the buccal and sublingual mucosa are vascularized and accessible, while also emphasizing that barriers still remain.

This area includes mucoadhesive films, gels, nanoparticles, enzyme inhibitors, permeation enhancers, and polymer-based systems. The research challenge is different from GI delivery but still substantial: residence time, saliva dilution, enzymatic activity, mucosal transport, irritation potential, and formulation stability all matter.

Why Transport Barriers Matter

Delivery is not just about getting a peptide near a tissue. It is about transport.

Peptides may need to move through mucus, across epithelial cells, between cells, through membranes, or into systemic circulation depending on the delivery route and research objective. Transport barriers are physical, chemical, and biological.

This is why delivery research increasingly uses combined tools:

In vitro barrier modelsEx vivo tissue systemsAnimal modelsComputational modelingBioanalytical methodsPermeability assaysStability testingImaging and tracking technologiesMathematical models of release and absorption

A 2026 review in Frontiers in Drug Delivery described oral peptide delivery research as focusing on functional excipients, translation of liquid prototypes into robust solid dosage formulations, and integration of in vitro, in vivo, and computational tools to improve predictive accuracy.

That last point is crucial. Peptide delivery research needs better prediction. A formulation that performs in one model may not translate cleanly to another.

Formulation Is Also an Analytical Problem

Peptide delivery systems can be difficult to analyze.

A formulation may include the peptide, counterions, surfactants, lipids, polymers, buffers, stabilizers, absorption enhancers, enzyme inhibitors, or other functional excipients. Researchers need methods that can measure the peptide itself, distinguish degradation products, characterize the carrier system, and evaluate release behavior.

Analytical questions may include:

Is the peptide intact?What impurities or degradation products are present?How much peptide is loaded into the carrier?How much remains free?What is the particle or droplet size?How does the formulation change over time?Does the system protect the peptide under simulated conditions?What happens after exposure to enzymes, pH shifts, or biological fluids?

This makes delivery research inseparable from quality science.

Manufacturing: The Hidden Barrier

Even promising delivery systems must eventually confront manufacturing.

Can the process be scaled?Can the formulation be made reproducibly?Are the excipients acceptable for the intended research or development pathway?Can the system be sterilized if needed?Can it survive filling, drying, storage, shipping, and handling?Does scale-up change performance?

Manufacturing is often where elegant laboratory formulations reveal practical weaknesses. A system that performs well in a small academic experiment may be difficult to scale, difficult to characterize, or difficult to produce consistently.

This is why formulation progress needs to be evaluated alongside process development. Delivery systems are not only scientific ideas. They are physical products that must be made.

Why the Field Remains So Active

Peptide delivery remains an active research topic because no single strategy solves every problem.

Some peptides may benefit from structural modification. Others may require carrier systems. Some delivery routes may require enzyme protection. Others may require permeability enhancement. Some systems may work in liquid form but need translation into solid dosage formats. Some may perform well in preclinical models but face challenges during scale-up or analysis.

The field is therefore moving through parallel lines of investigation:

Chemical modificationProdrug strategiesHydrophobic ion pairing, SEDDS and SNEDDSNanoparticles and nanomedicines, Mucoadhesive systems, Mucus-penetrating systems, Absorption enhancers, Enzyme inhibitors, 3D-printed dosage formsBuccal and sublingual systems, Computational modeling, Advanced in vitro barrier testingSolid dosage translation

The delivery problem is not one problem. It is a family of problems.

The Takeaway

Peptides are hard to formulate because they are complex molecules traveling through complex environments.

They may degrade before reaching the intended site. They may struggle to cross biological barriers. They may require protection from enzymes, careful control of pH, structural modification, carrier systems, or specialized dosage forms. They may present analytical and manufacturing challenges that are just as important as biological performance.

That is why peptide delivery has become such a credible research topic.

It brings together formulation science, synthetic chemistry, materials engineering, transport biology, analytical chemistry, bioanalysis, manufacturing, and regulatory thinking. It is where molecular promise meets physical reality.

The future of peptide research will not be shaped only by discovering new sequences.

It will also be shaped by learning how to deliver them.

Editor’s Note: This article is intended solely for research, educational, and industry discussion purposes. It does not promote, recommend, or imply any personal use, medical use, health benefit, treatment outcome, or therapeutic application of peptides or related compounds.